Endothelial-monocyte-activating polypeptide-II (EMAP-II) was first detected in supernatants of cultured murine tumour cells (Berger et al, 2000; Murray and Tas, 2001) based on its ability to stimulate procoagulant activity in cultured endothelial cells. This evidence concerns the gene AIMP1 and neoplasm.